GRUNENTHAL PHARMA LIMITED

Grünenthal Pharma Limited is a privately-owned, science-based pharmaceutical company operating in Ireland with a global focus on pain management and related diseases. As a fully integrated research and development organisation, Grünenthal brings innovative pain-treatment medicines and state-of-the-art technologies to patients, driven by the purpose of changing lives for the better and the vision of a world free of pain.

The company's core specialisation lies in developing new therapies for severe pain and high-unmet-need conditions, leveraging close collaborations with partners who share the same ambition. Grünenthal's commitment to responsible business is reflected in its annually published Responsibility Report, which follows Global Reporting Initiative standards and outlines its net-positive impact on patients, employees, partners and wider society.

With a workforce of over 4,400 scientists and professionals worldwide, Grünenthal continues to make significant progress in delivering innovative medicines, achieving record revenues and reinforcing its reputation as a leader in pain-relief research and development.